Diabetes

Patient hospitalised owing to incorrect dosing advice when switching insulin products

A national patient safety alert said patients had been incorrectly advised on the number of units to administer from Tresiba pre-filled insulin injection pens.…

‘Artificial pancreas’ offers better glycaemic control than standard therapy for pregnant women with type 1 diabetes, study reveals

Pregnant women treated with hybrid closed-loop therapy for type 1 diabetes mellitus spent less time at hyperglycaemic state, gained less maternal weight and had fewer hypertensive complications.…

Metformin for gestational diabetes does not increase preterm births, study results suggest 

The results also suggested that pregnant women given metformin were less likely to need insulin for their gestational diabetes.…

Tirzepatide more effective in blood sugar control and weight loss than semaglutide, meta-analysis finds

Analysis of 22 studies revealed that tirzepatide was more effective in reducing body weight than semaglutide at all respective doses.…

NICE recommends tirzepatide for type 2 diabetes in final draft guidance

Following additional analyses and modelling of clinical and cost effectiveness, the National Institute for Health and Care Excellence has recommended tirzepatide for type 2 diabetes mellitus.…

‘Limited’ supply of weight loss drug semaglutide launched in UK

Manufacturer Novo Nordisk said it will monitor demand and work with regulators to ensure Wegovy is accessible to eligible patients.…

Protecting our children’s future from global health threats

The pick of the latest academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…

Cost of NHS prescribing for diabetes rises by more than £500m since 2015/2016

Prescribing costs for diabetes items rose from £960m in 2015/2016 to 1.53bn in 2022/2023.…

National patient safety alert issued for GLP-1 receptor agonists

The alert warns healthcare providers not to switch between brands or double up on lower-dose preparations when the higher dose is unavailable.…

The use of insulin biobetters and biosimilars in the UK

An overview of the issues surrounding biosimilar insulins.…